What happened?
On February 8, 2025, a report by Bain & Company revealed that India’s pharmaceutical exports are projected to grow significantly. The report, titled Healing the World: Roadmap for Making India a Global Pharma Exports Hub, forecasts that exports will double from approximately $27 billion in 2023 to $65 billion by 2030 and could reach $350 billion by 2047. The report was unveiled during the Indian Drug Manufacturers Association’s (IDMA) 63rd Annual Day event in Mumbai by Union Minister of Commerce and Industry, Shri Piyush Goyal.
Why it matters to India:
This growth target aligns with India’s ambition to transition from the “pharmacy of the world” to the “healthcare custodian of the world.” While India is the largest global supplier of generic drugs, it ranks 11th in export value. The expansion of the pharmaceutical sector is crucial to India’s vision of becoming a global healthcare leader, contributing to economic growth, fostering innovation, and establishing the country as a top player in the global healthcare ecosystem.